Oxytocin against dementia

Philippos Koulousakis was born and raised in Cologne, Germany. He obtained his Research Master in Fundamental Neuroscience at the University of Maastricht in 2015 after gaining his BSc in Psychology and Neuroscience at Maastricht as well. During his master internship at Cambridge University, he helped establish a drug-screening method for Alzheimer’s disease using transgenic zebrafish. After graduating, he decided to go back to his roots and do psychotherapist training in Cologne from 2016 to 2018. However, in those two years he noticed that he was missing academia, and therefore decided to go back to it by working as a research assistant at the University of Cologne. Since 2020, he is a PhD student at the University of Maastricht and University of Hasselt. He explores epigenetic editing of oxytocin as a potential treatment avenue for Alzheimer’s disease.